I-Mab to Participate at the Piper Sandler Healthcare Conference

Rhea-AI Summary

I-Mab (NASDAQ: IMAB), a U.S.-based global biotech company focused on cancer immunotherapies, has announced its participation in the Piper Sandler 36th Annual Healthcare Conference in New York from December 3-5, 2024. The company's management team will deliver a presentation on December 4 at 4:30 p.m. ET. Key participants include CEO Sean Fu, CMO Phillip Dennis, CFO Joseph Skelton, and Senior Director of IR Tyler Ehler. The event will feature one-on-one and small group meetings during December 3-4. A webcast of the presentation will be accessible through the company's IR website.

News Market Reaction

-2.14%

1 alert

-2.14% News Effect

On the day this news was published, IMAB declined 2.14%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

The 36^th Annual Healthcare Conference will be held in New York, December 3-5, 2024

ROCKVILLE, Md., Nov. 21, 2024 /PRNewswire/ -- I-Mab (NASDAQ: IMAB, the "Company"), a U.S.-based global biotech company, exclusively focused on the development of highly differentiated immunotherapies for the treatment of cancer, today announced that management will present at the Piper Sandler 36th Annual Healthcare Conference on December 4, 2024.

Piper Sandler 36th Annual Healthcare Conference Presentation Details

Presentation Time	Wednesday, December 4 at 4:30 p.m. ET
Presenters	Sean Fu, PhD, MBA, Chief Executive Officer Phillip Dennis, MD, PhD, Chief Medical Officer
Webcast link	Here
Meetings	One-on-one and small group meetings: December 3 – 4, 2024
Management Participants	Sean Fu, PhD, MBA, Chief Executive Officer Joseph Skelton, Chief Financial Officer Phillip Dennis, MD, PhD, Chief Medical Officer Tyler Ehler, Senior Director, Investor Relations

The webcast will also be available under "Event Calendar" on I-Mab's IR website
at https://ir.i-mabbiopharma.com/

For more information, please contact your Piper Sandler representative.

About I-Mab

I-Mab (NASDAQ: IMAB) is a US-based, global biotech company, exclusively focused on the development of highly differentiated immunotherapies for the treatment of cancer. I-Mab has established operations in Rockville, Maryland, and Short Hills, New Jersey. For more information, please visit https://www.i-mabbiopharma.com and follow us on LinkedIn and X.

For more information, please contact:

Tyler Ehler
Senior Director, Investor Relations
IR@imabbio.com 

View original content to download multimedia:https://www.prnewswire.com/news-releases/i-mab-to-participate-at-the-piper-sandler-healthcare-conference-302312202.html

SOURCE I-Mab Biopharma

FAQ

When is I-Mab (IMAB) presenting at the Piper Sandler Healthcare Conference 2024?

I-Mab will present on Wednesday, December 4, 2024, at 4:30 p.m. ET during the Piper Sandler 36th Annual Healthcare Conference.

Who are the key presenters from I-Mab (IMAB) at the Piper Sandler Conference 2024?

The key presenters are Sean Fu (CEO) and Phillip Dennis (CMO), with Joseph Skelton (CFO) and Tyler Ehler (Senior Director, IR) also participating in meetings.

Where can I watch I-Mab's (IMAB) Piper Sandler Conference presentation?

The presentation webcast will be available on I-Mab's IR website under the 'Event Calendar' section at ir.i-mabbiopharma.com.

What type of meetings is I-Mab (IMAB) conducting at the Piper Sandler Conference 2024?

I-Mab is conducting one-on-one and small group meetings during December 3-4, 2024.